ERT Helps Medical Researchers Accelerate Clinical Trials with AI-Assistance from Dynatrace
May 28 2020 - 8:00AM
Business Wire
Advanced observability speeds DevOps process
and assures optimal performance of clinical trial solutions to
drive faster time-to-market for new treatments and vaccines
Software intelligence company Dynatrace (NYSE: DT), today
announced that ERT – a developer of software and devices used by
medical researchers in 75% of FDA approved clinical trials in 2019
– is using Dynatrace® to automate DevOps processes, and speed up
delivery of new applications, from an average of six weeks to as
little as two weeks. These applications help researchers worldwide
conduct clinical trials safely and effectively and bring new
treatments and vaccines to market faster. They also gather data and
produce reports, supplying researchers with the evidence they need
to secure approval for new medical advancements from the FDA and
other regulators around the world.
“Our solutions are critical to our customers’ ability to get
new, potentially life-saving treatments out of the laboratory and
into hospitals and pharmacies,” said Simon Pilar, Director of IT
Service Operations, ERT. “Given the high-stakes nature of their
business, our customers can’t afford to miss important patient data
or medical alerts during clinical trials, so we have to ensure the
highest levels of quality, reliability, and performance in our solutions. At the same
time, we need to challenge ourselves to continually increase the
speed of innovation, to help our customers accelerate their trials.
By providing advanced observability across our DevOps processes and
app delivery pipelines, Dynatrace allows us to see the smoke before
the fire starts to burn. We can stop bad code from ever reaching
production, so it never becomes a problem.”
The Dynatrace® AI engine, Davis™, continuously monitors ERT’s
DevOps processes and app delivery pipelines, watching for errors,
degradations, and regressions. Davis automatically prioritizes any
issues based on impact, saving developers time, and ensuring the
DevOps team can find, understand, and resolve issues before they
impact clinical trials. ERT also uses Keptn, Dynatrace’s open
source control plane for cloud-native continuous delivery and
operations. With Keptn, issues found by Davis can trigger automatic
self-healing actions. This enables ERT to reduce development time
while ensuring the highest standards of quality and precision.
“One of the major benefits of Dynatrace is that it’s so easy to
use,” Pilar added. “We were able to deploy it in minutes. Dynatrace
instantly illuminated our entire environment and started surfacing
insights to our DevOps team, providing value within hours, not
weeks or months. Davis, the AI engine, automatically identifies the
root cause of any problems that arise, saving us time and giving us
the confidence to automate our delivery pipelines. Dynatrace
fundamentally changes the way we work, and allows our teams to
deliver software innovation faster, without wasted time and
effort.”
Visit the Dynatrace Customer Stories page for more details on
how ERT is accelerating clinical trials innovation with Dynatrace®
and Keptn.
About Dynatrace
Dynatrace provides software intelligence to simplify cloud
complexity and accelerate digital transformation. With advanced
observability, AI and complete automation, our all-in-one platform
provides answers, not just data, about the performance of
applications, the underlying infrastructure, and the experience of
all users. That’s why many of the world’s largest enterprises trust
Dynatrace® to modernize and automate cloud operations, release
better software faster, and deliver unrivaled digital
experiences.
Curious to see how you can simplify your cloud? Let us show you.
Visit our trial page for a free 15-day Dynatrace trial.
To learn more about how Dynatrace can help your business, visit
https://www.dynatrace.com, visit our blog and follow us on Twitter
@dynatrace.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200528005092/en/
Hailey Melamut March Communications dynatrace@marchcomms.com +1
617.960.9856
Tristan Webb Spark Communications dynatrace@sparkcomms.co.uk +44
207.436.0420
Dynatrace (NYSE:DT)
Historical Stock Chart
From Aug 2024 to Sep 2024
Dynatrace (NYSE:DT)
Historical Stock Chart
From Sep 2023 to Sep 2024